Related Experiment Video
Updated: Oct 10, 2025
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
9.9K
Behavioral interventions to reduce particulate matter exposure in patients with COPD
Jieun Kang1, Ji Ye Jung2, Jin-Young Huh3
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea.
Medicine
|December 10, 2021
Summary
This study investigates if behavioral changes can reduce particulate matter exposure for COPD patients. Findings will offer practical strategies for managing air pollution
Area of Science:
- Environmental Health
- Pulmonary Medicine
- Behavioral Science
Background:
- Particulate matter (PM) exposure is a significant risk factor for chronic obstructive pulmonary disease (COPD).
- Limited evidence exists on the effectiveness of individual-level interventions to mitigate PM exposure in COPD patients.
- This study addresses the need for evidence-based strategies to reduce daily PM exposure for those with COPD.
Purpose of the Study:
- To evaluate the clinical efficacy of behavioral interventions aimed at reducing PM exposure in COPD patients.
- To assess the impact of these interventions on respiratory health outcomes and quality of life.
Main Methods:
- A multicenter randomized controlled trial involving 120 COPD patients (aged 40-80).
- Intervention group received guidance on checking air quality, using air cleaners, ventilation, adhering to treatment, and limiting outdoor activity on high pollution days.
- PM exposure measured using IoT, gravimetric, and light-scattering methods; individual exposure estimated via time-activity diaries and land use regression modeling.
Main Results:
- Analysis will focus on changes in PM exposure, forced expiratory volume at 1-second (FEV1), respiratory symptoms, quality of life, and rates of exacerbation, hospitalization, and mortality.
- The study aims to quantify the impact of behavioral interventions on these clinical outcomes.
Conclusions:
- Behavioral interventions to reduce PM exposure may offer significant benefits for COPD management.
- This research will provide physicians and patients with actionable, evidence-based strategies for mitigating the effects of air pollution in daily life.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
457
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
457
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.4K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:23Inhaled Medications
464
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
464
01:22Chronic Obstructive Pulmonary Disease
1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K